Up until now strict French laws have prevented parents in France from harvesting their baby’s stem cells. In fact, no institution is allowed to keep blood samples for an individual “just in case’ medical advances may one day render them useful.
Professor Ibrahim Yakoub-Agha, a haematologist at Lille University Hospital, said medical professionals in France were concerned that the court’s decision could represent a president.
Regenerative medicine
For many parents, cord blood banking is seen as an investment in the future health of their child and it is estimated that 1 in 3 people may benefit from a regenerative treatment in their lifetime. In fact, stem cells are currently being investigated in clinical trial to treat very common conditions like heart attack, stroke, cartilage damage, bone injury, burns, ulcers and many others.
It is welcome news that the French court recognised the potential of cord blood stem cells when he cleared the family to collect the umbilical and placental blood as a “wholly justified therapeutic necessity”.

